SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-11-018308
Filing Date
2011-03-30
Accepted
2011-03-30 16:33:50
Documents
2
Effectiveness Date
2011-03-30

Document Format Files

Seq Description Document Type Size
1 v216698_8k.htm DEFA14A 35028
2 v216698_ex99-1.htm EX-99.1 43265
  Complete submission text file 0001144204-11-018308.txt   79323
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEFA14A | Act: 34 | File No.: 000-25169 | Film No.: 11722507
SIC: 2834 Pharmaceutical Preparations